Ekso Bionics Holdings, Inc. (EKSO:NASDAQ) closed at $11.80 on May 15, 2026, up 1.29% on the day. The stock trades 12.6% below its 52-week high of $13.50 and 332.2% above its 52-week low of $2.73. Ekso Bionics Holdings, Inc. is part of the Capital Goods sector (Industrial Machinery/Components).
In 252 trading sessions since October 22, 2025, EKSO closed higher on 70 days (28%). Its best day was December 30, 2025 (+93.77%) and its worst was December 31, 2025 (-18.34%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 2 times.
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company's Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation to develop products for military applications, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.
Find more stocks like EKSO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.